IDEAYA Biosciences, Inc.
IDYA
$17.45
-$0.90-4.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -138.25% | -142.98% | -72.59% | -107.33% | -88.77% |
| Total Depreciation and Amortization | -5.93% | -4.34% | 7.91% | 11.14% | 12.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 271.98% | 65.99% | 0.05% | -36.45% | -52.07% |
| Change in Net Operating Assets | 287.42% | 187.42% | 169.90% | 127.65% | 72.42% |
| Cash from Operations | -101.31% | -114.87% | -30.33% | -20.01% | -37.56% |
| Capital Expenditure | -5.81% | -62.88% | -134.84% | -84.37% | -18.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.81% | -219.50% | -648.84% | -174.28% | -4,955.40% |
| Cash from Investing | 87.17% | -217.16% | -634.99% | -172.84% | -6,903.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -48.23% | 108.45% | 327.37% | 115.84% | 570.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -77.72% | -77.72% | -53.18% | -79.98% | 468,588.89% |
| Cash from Financing | -49.98% | 86.80% | 267.19% | 92.07% | 612.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.04% | -181.53% | 392.20% | 47.91% | 249.56% |